Cart
sales@molnova.com
Acetylarenobufagin
CAS No. 184673-79-8
Acetylarenobufagin( —— )
Catalog No. M32768 CAS No. 184673-79-8
Acetylarenobufagin is a steroidal hypoxia-inducible factor-1 (HIF-1) modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 169 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 394 | In Stock |
|
| 25MG | 621 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcetylarenobufagin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetylarenobufagin is a steroidal hypoxia-inducible factor-1 (HIF-1) modulator.
-
DescriptionAcetylarenobufagin is a steroidal hypoxia inducible factor-1 (HIF-I) modulator.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorHIF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number184673-79-8
-
Formula Weight458.54
-
Molecular FormulaC26H34O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@]12[C@@](O)([C@]3([C@]([C@H](O)C1=O)([C@]4(C)[C@](CC3)(C[C@@H](OC(C)=O)CC4)[H])[H])[H])CC[C@@H]2C=5C=CC(=O)OC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mehran Khodadoust, et al. Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders.
molnova catalog
related products
-
Molidustat
Molidustat (BAY 85-3934) is an orally active small molecule inhibitor of hypoxia inducible factor prolyl hydroxylase (HIF-PH) with IC50 of 480 nM, 280 nM and 450 nM for PHD1, PHD2, and PHD3, respectively.
-
Naphthofluorescein
Naphthofluorescein （Naphthafluorescein） is a Mint3 inhibitor with potential antitumor and anti-inflammatory activities, inhibits the interaction between HIF-1 and Mint3, inhibits Mint3-dependent HIF-1 activity, and inhibits glycolytic activity in cancer cells and macrophages without showing significant in vitro cytotoxicity or in vivo side effects.
-
Adaptaquin
Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).
